124 related articles for article (PubMed ID: 37586925)
1. Comparison of Survival Outcomes in Young Patients With Breast Cancer Receiving Contralateral Prophylactic Mastectomy Versus Unilateral Mastectomy.
Huang H; Wei T; Zhang A; Zhang H; Kong L; Li Y; Li F
Clin Breast Cancer; 2023 Oct; 23(7):752-762.e7. PubMed ID: 37586925
[TBL] [Abstract][Full Text] [Related]
2. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
Yang Y; Pan L; Shao Z
Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
[TBL] [Abstract][Full Text] [Related]
3. No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma.
Yu TJ; Liu YY; Hu X; Di GH
J Surg Oncol; 2018 Nov; 118(6):928-935. PubMed ID: 30311653
[TBL] [Abstract][Full Text] [Related]
4. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
[TBL] [Abstract][Full Text] [Related]
5. Contralateral prophylactic mastectomy for unilateral breast cancer in Chinese female population: a retrospective cohort study.
Zhu J; Min N; Zhang Y; Wu H; Hong C; Geng R; Wei Y; Guan Q; Zheng Y; Li X
Gland Surg; 2023 Dec; 12(12):1668-1685. PubMed ID: 38229836
[TBL] [Abstract][Full Text] [Related]
6. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
Agarwal S; Pappas L; Matsen CB; Agarwal JP
Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
[TBL] [Abstract][Full Text] [Related]
7. Trends of incidence and mortality in metaplastic breast cancer and the effect of contralateral prophylactic mastectomy: A population-based study.
Wu P; Chang H; Wang Q; Shao Q; He D
Asian J Surg; 2024 Jan; 47(1):394-401. PubMed ID: 37739898
[TBL] [Abstract][Full Text] [Related]
8. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.
Kruper L; Kauffmann RM; Smith DD; Nelson RA
Ann Surg Oncol; 2014 Oct; 21(11):3448-56. PubMed ID: 25047478
[TBL] [Abstract][Full Text] [Related]
10. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
Hawley ST; Jagsi R; Morrow M; Janz NK; Hamilton A; Graff JJ; Katz SJ
JAMA Surg; 2014 Jun; 149(6):582-9. PubMed ID: 24849045
[TBL] [Abstract][Full Text] [Related]
11. Breast-conserving surgery is an appropriate procedure for centrally located breast cancer: a population-based retrospective cohort study.
Yuan YW; Liu PC; Li FF; Yang YH; Yang W; Fan L; Mou DW; Yang HW; Chen MS
BMC Surg; 2023 Oct; 23(1):298. PubMed ID: 37789365
[TBL] [Abstract][Full Text] [Related]
12. Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.
Brewster AM; Bedrosian I; Parker PA; Dong W; Peterson SK; Cantor SB; Crosby M; Shen Y
Cancer; 2012 Nov; 118(22):5637-43. PubMed ID: 22517269
[TBL] [Abstract][Full Text] [Related]
13. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.
Bedrosian I; Hu CY; Chang GJ
J Natl Cancer Inst; 2010 Mar; 102(6):401-9. PubMed ID: 20185801
[TBL] [Abstract][Full Text] [Related]
14. Contralateral prophylactic mastectomy rate stable at major Canadian breast cancer center.
Roberts A; Sandhu L; Cil TD; Hofer SO; Zhong T
World J Clin Oncol; 2016 Jun; 7(3):302-7. PubMed ID: 27298770
[TBL] [Abstract][Full Text] [Related]
15. Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.
Jatoi I; Parsons HM
Breast Cancer Res Treat; 2014 Nov; 148(2):389-96. PubMed ID: 25301088
[TBL] [Abstract][Full Text] [Related]
16. Financial toxicity and contralateral prophylactic mastectomy: an analysis using propensity score methods.
Asaad M; Boukovalas S; Chu CK; Lin YL; Checka CM; Clemens MW; Greenup RA; Offodile AC
Breast Cancer Res Treat; 2020 Oct; 183(3):649-659. PubMed ID: 32691378
[TBL] [Abstract][Full Text] [Related]
17. Nomogram Predicts the Role of Contralateral Prophylactic Mastectomy in Male Patients With Unilateral Breast Cancer Based on SEER Database: A Competing Risk Analysis.
Li K; Wang B; Yang Z; Yu R; Chen H; Li Y; He J; Zhou C
Front Oncol; 2021; 11():587797. PubMed ID: 33996535
[TBL] [Abstract][Full Text] [Related]
18. Contralateral prophylactic mastectomy: Weighing the risks of delayed chemotherapy, radiotherapy, and hormonal therapy.
Clapp A; Murphy AI; Ascherman JA; Rohde CH
J Plast Reconstr Aesthet Surg; 2024 Feb; 89():7-13. PubMed ID: 38118362
[TBL] [Abstract][Full Text] [Related]
19. Survival Comparisons between Breast Conservation Surgery and Mastectomy Followed by Postoperative Radiotherapy in Stage I-III Breast Cancer Patients: Analysis of the Surveillance, Epidemiology, and End Results (Seer) Program Database.
Xiang W; Wu C; Wu H; Fang S; Liu N; Yu H
Curr Oncol; 2022 Aug; 29(8):5731-5747. PubMed ID: 36005190
[TBL] [Abstract][Full Text] [Related]
20. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience.
Miller ME; Czechura T; Martz B; Hall ME; Pesce C; Jaskowiak N; Winchester DJ; Yao K
Ann Surg Oncol; 2013 Dec; 20(13):4113-20. PubMed ID: 23868655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
